Literature DB >> 28645438

Sacubitril/valsartan in PARADIGM-HF.

Nicolas Vodovar1, Hélène Nougué2, Jean-Marie Launay3, Alain Cohen Solal4, Damien Logeart4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28645438     DOI： 10.1016/S2213-8587(17)30177-8

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  6 in total

Review 1.  Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

Authors:  Nathalie Esser; Sakeneh Zraika
Journal:  Diabetologia       Date:  2019-05-14       Impact factor: 10.122

2.  Neprilysin inhibition improves intravenous but not oral glucose-mediated insulin secretion via GLP-1R signaling in mice with β-cell dysfunction.

Authors:  Nathalie Esser; Stephen M Mongovin; Jacqueline Parilla; Breanne M Barrow; Thomas O Mundinger; Brendy S Fountaine; Megan J Larmore; Joseph J Castillo; Rehana Akter; Rebecca L Hull; Sakeneh Zraika
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-02-07       Impact factor: 4.310

3.  Neprilysin Deficiency Is Associated With Expansion of Islet β-Cell Mass in High Fat-Fed Mice.

Authors:  Jacqueline H Parilla; Rebecca L Hull; Sakeneh Zraika
Journal:  J Histochem Cytochem       Date:  2018-03-19       Impact factor: 2.479

Review 4.  Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment.

Authors:  Koichi Yamamoto; Hiromi Rakugi
Journal:  Hypertens Res       Date:  2021-07-21       Impact factor: 3.872

Review 5.  Potential mechanisms of beneficial effect of sacubitril/valsartan on glycemic control.

Authors:  Jelena P Seferovic; Scott D Solomon; Ellen W Seely
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-25       Impact factor: 3.565

6.  Effects of sacubitril/valsartan on both metabolic parameters and insulin resistance in prediabetic non-obese patients with heart failure and reduced ejection fraction.

Authors:  Cosima Cloro; Isabella Zaffina; Luca Sacchetta; Federico Arturi; Cristina Clausi; Stefania Lucà; Maria Chiara Pelle; Federica Giofrè; Giuseppe Armentaro; Valentina Forte; Francesco Mario De Rosa; Angela Sciacqua; Franco Arturi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-10       Impact factor: 6.055
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.